Baxter International Inc. $BAX Holdings Lifted by Murphy Pohlad Asset Management LLC

Murphy Pohlad Asset Management LLC grew its position in Baxter International Inc. (NYSE:BAX) by 53.8% in the 3rd quarter, Holdings Channel.com reports. The firm owned 92,868 shares of the medical instruments supplier’s stock after buying an additional 32,467 shares during the period. Murphy Pohlad Asset Management LLC’s holdings in Baxter International were worth $2,229,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently made changes to their positions in the company. Jones Financial Companies Lllp bought a new stake in shares of Baxter International during the second quarter valued at approximately $26,000. CYBER HORNET ETFs LLC boosted its position in shares of Baxter International by 52.4% during the second quarter. CYBER HORNET ETFs LLC now owns 2,153 shares of the medical instruments supplier’s stock worth $46,000 after buying an additional 740 shares during the period. Community Bank N.A. acquired a new position in shares of Baxter International during the second quarter worth approximately $46,000. Versant Capital Management Inc boosted its position in shares of Baxter International by 552.2% during the second quarter. Versant Capital Management Inc now owns 2,413 shares of the medical instruments supplier’s stock worth $51,000 after buying an additional 2,043 shares during the period. Finally, EFG International AG bought a new position in Baxter International in the 2nd quarter worth approximately $67,000. Institutional investors and hedge funds own 90.19% of the company’s stock.

Baxter International Price Performance

Shares of NYSE:BAX traded down $0.33 during trading on Friday, reaching $25.32. The company had a trading volume of 4,936,022 shares, compared to its average volume of 6,154,588. The firm’s fifty day moving average is $24.76 and its 200 day moving average is $22.15. The firm has a market capitalization of $13.09 billion, a PE ratio of -12.23, a price-to-earnings-growth ratio of 3.88 and a beta of 0.65. Baxter International Inc. has a twelve month low of $15.73 and a twelve month high of $30.00. The company has a debt-to-equity ratio of 1.39, a quick ratio of 1.32 and a current ratio of 1.95.

Baxter International (NYSE:BAX) last posted its quarterly earnings data on Thursday, July 30th. The medical instruments supplier reported $0.56 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.19. Baxter International had a negative net margin of 9.27% and a positive return on equity of 16.57%. The business had revenue of $2.96 billion for the quarter, compared to analyst estimates of $2.80 billion. During the same quarter last year, the business earned $0.59 earnings per share. The business’s revenue for the quarter was up 5.3% on a year-over-year basis. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS. On average, equities analysts forecast that Baxter International Inc. will post 2.04 EPS for the current year.

Baxter International Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, October 1st. Shareholders of record on Friday, August 28th were paid a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend was Friday, August 28th. Baxter International’s dividend payout ratio (DPR) is presently -1.93%.

Analysts Set New Price Targets

Several analysts recently commented on the company. Wall Street Zen cut Baxter International from a “buy” rating to a “hold” rating in a research report on Saturday, October 10th. Stifel Nicolaus lifted their target price on Baxter International from $19.00 to $24.00 and gave the company a “hold” rating in a research note on Tuesday, July 28th. Weiss Ratings lowered Baxter International from a “sell (d)” rating to a “sell (d-)” rating in a research report on Thursday, October 8th. Zacks Research raised Baxter International from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 11th. Finally, The Goldman Sachs Group increased their price target on Baxter International from $19.00 to $21.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 15th. One research analyst has rated the stock with a Buy rating, ten have assigned a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Reduce” and an average target price of $21.73.

About Baxter International

Baxter International Inc is a global medical products and healthcare technology company headquartered in Deerfield, Illinois. The company develops, manufactures and distributes products used in hospitals, clinics, ambulatory care centers and other healthcare settings.

Baxter’s portfolio has included intravenous therapies and administration systems, infusion pumps, connected-care technologies, surgical products, patient monitoring equipment and products used in medication preparation and delivery.